ネガティブアロステリックモジュールで調節されるGPR3のメカニズムと機能
Geng Chen1,2,3, Jana Bláhová4, Nico Staffen4
1School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China.
Nature communications
|August 27, 2025
まとめ
研究者達は,薬がGタンパク質結合受容体 (GPCRs) をブロックする新しい方法を発見しました. AF64394という薬は GPR3ジマーを標的にし 信号伝達を阻害し 代謝や中枢神経障害の治療に 新たな道を開きます
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- Gタンパク質結合受容体 (GPCRs) は重要な薬物標的である.
- アロステリック調節器は,GPCR活性に対する正確な制御を提供します.
- GPR3は代謝および中枢神経系の障害に関与しています.
研究 の 目的:
- GPR3のアロステリック調節のメカニズムを解明する.
- その機能における GPR3 ダイメリゼーションの役割を調べる
- AF64394による抑制の構造的基礎を決定する.
主な方法:
- GPR3の二分化とシグナル伝達を研究する細胞解析.
- 構造を決定するための冷凍電子顕微鏡 (冷凍-EM).
- Gタンパク質の結合を分析する生化学分析
主要な成果:
- GPR3は,生きている細胞で構成ホモディマーを形成する.
- AF64394は二次性GPR3を標的とするネガティブアロステリック変調子 (NAM) として作用する.
- Cryo-EM構造は,ダイマー界面でAF64394結合を明らかにし,不活性な形状を安定させ,Gs結合を減少させます.
結論:
- AF64394はダイマー特異的なメカニズムを通してGPR3の信号伝達を阻害する.
- この研究は,GPCRジマーを標的とした新しいアロステリック阻害戦略を明らかにした.
- この発見は,二重GPCRを標的とする代謝および中枢神経系の疾患に対する薬の開発に重大な意味を持つ.
さらに関連する動画
関連する概念動画
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Activation and Inactivation of G Proteins
7.6K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.6K
G-Protein Gated Ion Channels
4.8K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.8K
G Protein-coupled Receptors
13.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.3K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Transducer Mechanism: G Protein–Coupled Receptors
2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.4K


